₹9,756 on March 7 before undergoing a 38% correction, settling at ₹5,960 by the end of last week. This sharp decline over 10 days translated into a staggering loss of nearly ₹20,000 crore in market capitalization. Consequently, the company's market cap dwindled from ₹49,365 crore on March 7 to ₹30,155 crore within a span of two weeks.
Also read: Multibagger stock: HEG skyrocketed over 105% in a year, up 365% in 4 years; should you still buy? During the week when Spark Capital discussed the possibility of Tata Sons' potential listing by September 2025, the stock experienced consecutive upper circuits of 5%. The likelihood of Tata Sons going public is slim, as the group explores strategies to comply with RBI regulations. Among the options considered are reducing group-level debt and restructuring entities like Tata Capital.
In addition, Tata Sons has divested 0.64% of its stake in the lucrative Tata Consultancy Services Ltd. (TCS), fetching approximately ₹9,000 crore. Other Tata Group companies such as Tata Chemicals, currently under the F&O ban, along with Tata Consumer Products and TCS, have all witnessed a 7.5% decline this week.
Also read: With elevated room rates, Q4 to be another strong quarter for hotel sector, says Emkay; adds Lemon Tree, IHCL, Chalet Tata Consumer shares saw a drop following CLSA's initiation of coverage on the stock with an underweight rating, citing stretched valuations and limited upside potential. TCS's decline mirrors the broader pessimism surrounding technology stocks, exacerbated by Accenture's downward revision of revenue growth forecasts for the current financial year due to sluggish recovery in the discretionary segment. Milestone Alert!
Livemint tops charts as the fastest growing news